Breaking News
Get 55% Off 0
🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAY
CLAIM SALE
Close

Abbott Laboratories (ABT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2,390.00 0.00    0.00%
05/11 - Delayed Data. Currency in MXN
  • Volume: 0
  • Bid/Ask: 2,300.41 / 2,600.00
  • Day's Range: 2,380.00 - 2,390.00
Type:  Equity
Market:  Mexico
ISIN:  US0028241000 
S/N:  002824100
Abbott Labs 2,390.00 0.00 0.00%

ABT Financial Summary

 
A brief financial summary of Abbott Laboratories as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

Abbott Laboratories reported earnings results for the third quarter and nine months ended September 30, 2024. For the third quarter, the company reported sales was USD 10,635 million compared to USD 10,143 million a year ago. Net income was USD 1,646 million compared to USD 1,436 million a year ago. Diluted earnings per share from continuing operations was USD 0.94 compared to USD 0.82 a year ago. For the nine months, sales was USD 30,976 million compared to USD 29,868 million a year ago. Net income was USD 4,173 million compared to USD 4,129 million a year ago. Diluted earnings per share from continuing operations was USD 2.38 compared to USD 2.35 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

ABT Income Statement

Gross margin TTM 55.91%
Operating margin TTM 17.99%
Net Profit margin TTM 13.99%
Return on Investment TTM 12.19%
 Total Revenue  Net Income
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Total Revenue 10635 10377 9964 10241
Gross Profit 5937 5853 5512 5710
Operating Income 1994 1927 1535 2057
Net Income 1646 1302 1225 1594

ABT Balance Sheet

Quick Ratio MRQ 1
Current Ratio MRQ 1.6
LT Debt to Equity MRQ 32.36%
Total Debt to Equity MRQ 37.81%
 Total Assets  Total Liabilities
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Total Assets 74356 73017 72467 73214
Total Liabilities 34328 33457 33424 34387
Total Equity 40028 39560 39043 38827

ABT Cash Flow Statement

Cash Flow/Share TTM 5.02
Revenue/Share TTM 23.69
Operating Cash Flow  18.15%
 Cash  Net Change in Cash
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 2705 1960 1025 3038
Cash From Investing Activities -594 -453 -425 -824
Cash From Financing Activities -1576 -791 -1176 -2052
Net Change in Cash 571 703 -612 187
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ABT Comments

Write your thoughts about Abbott Laboratories
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
grant mclean
grant mclean Dec 22, 2021 15:19
Saved. See Saved Items.
This comment has already been saved in your Saved Items
anyone watching
Larry Taylor
Larry Taylor Jan 25, 2021 10:25
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Going to $120
Larry Taylor
Larry Taylor Jan 25, 2021 10:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Going to $120
nikhil bhardwaj
nikhil bhardwaj Apr 16, 2020 8:28
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Dropping to low 80s on a bad earnings then maybe rebound
grant mclean
grant mclean Apr 16, 2020 8:28
Saved. See Saved Items.
This comment has already been saved in your Saved Items
so much for that prediction
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email